You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,543,192


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,543,192 protect, and when does it expire?

Patent 10,543,192 protects QBREXZA and is included in one NDA.

This patent has twenty-seven patent family members in thirteen countries.

Summary for Patent: 10,543,192
Title:Glycopyrrolate salts
Abstract: Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed. Methods of making glycopyrrolate salts, including formulations such as topicals thereof, and methods of treating hyperhidrosis with salts of glycopyrrolate, and formulations such as topicals thereof, are disclosed.
Inventor(s): Statler; John Allan (Redwood City, CA), Shaw; Anthony Adrian (North Vancouver, CA), Imbert; Delphine Caroline (Cupertino, CA), Nelson; Jennifer Leigh (Kokomo, IN), Andres; Patricia (West Lafayette, IN), McQueen; Lisa Lynn (West Lafayette, IN), Boerrigter; Stephan Xander Mattheus (West Lafayette, IN), Selbo; Jon Gordon (West Lafayette, IN), Andres; Mark Christopher (West Lafayette, IN)
Assignee: Dermira, Inc. (Menlo Park, CA)
Application Number:15/996,353
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,543,192
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,543,192

Introduction

Understanding the scope and claims of a patent is crucial for navigating the complex landscape of intellectual property. This article will delve into the specifics of United States Patent 10,543,192, exploring its claims, scope, and the broader patent landscape it operates within.

Patent Overview

United States Patent 10,543,192, hereafter referred to as the '192 patent, is a utility patent issued by the United States Patent and Trademark Office (USPTO). To analyze this patent, one must first identify its title, inventors, assignees, and the date of issuance.

Title and Inventors

The title of the patent provides a brief description of the invention. For example, if the '192 patent is related to "Topical Glycopyrrolate Formulations" like similar patents in the same field[2], it would indicate that the invention pertains to formulations used for topical application.

Assignees and Licensees

The assignee of the patent is the entity that owns the rights to the invention. In many cases, the assignee may not be the inventor but rather a company or organization that has acquired the rights. For instance, Rose U, LLC could be the assignee, with Dermira, Inc. as the exclusive licensee[2].

Claims Analysis

Independent and Dependent Claims

Patent claims are the heart of any patent, defining the scope of protection. Independent claims stand alone and define the invention broadly, while dependent claims build upon the independent claims and provide more specific details[3].

  • Independent Claim Length and Count: Research suggests that the length and count of independent claims can be metrics for measuring patent scope. Narrower claims, as indicated by shorter lengths and fewer counts, are often associated with a higher probability of grant and a shorter examination process[3].

  • Claim Specificity: The specificity of claims is crucial. Broader claims may face more scrutiny during the examination process and are more likely to be narrowed down to ensure clarity and validity[3].

Claim Limitations

Each claim includes limitations that define what is protected. For the '192 patent, these limitations would be detailed in the claim language, specifying what constitutes infringement. For example, if the patent involves a topical glycopyrrolate formulation, the claims might include limitations on the composition, method of application, and intended use[2].

Patent Scope

Breadth of Protection

The scope of a patent determines the breadth of protection it offers. Patents with broader claims may cover a wider range of applications but are also more likely to face challenges during the examination process and in litigation[3].

  • Patent Maintenance Payments: The scope of a patent can also be inferred from maintenance payments. Patents with narrower claims tend to have lower maintenance costs, indicating a more focused and potentially more valuable invention[3].

  • Forward Citations: The number of forward citations a patent receives can also indicate its scope and impact. Patents with broader claims may receive more citations as they are more likely to be relevant to a wider range of subsequent inventions[3].

Patent Landscape

Industry Context

The '192 patent operates within a specific industry context, such as pharmaceuticals or dermatology if it pertains to topical glycopyrrolate formulations. Understanding the industry trends, competitors, and regulatory environment is essential for assessing the patent's value and potential for litigation.

  • Regulatory Environment: Changes in laws and regulations, such as the Leahy-Smith America Invents Act (AIA), can significantly impact the patent landscape. For instance, the AIA introduced changes that affected the number of defendants in lawsuits and the types of patents involved in litigation[4].

Litigation and Enforcement

Patent litigation is a critical aspect of the patent landscape. The '192 patent, like other patents, could be involved in infringement lawsuits or inter partes review (IPR) petitions.

  • Non-Practicing Entities (NPEs): The involvement of NPEs, entities that own patents but do not make products, can significantly impact patent litigation. These entities often focus on licensing and asserting patents for profit, which can lead to increased litigation costs and complexity[4].

Search and Analysis Tools

To analyze the '192 patent thoroughly, several tools and resources are available:

  • USPTO Public Search Facility: This facility provides access to comprehensive patent databases, allowing for detailed searches of issued patents and published patent applications[1].

  • Patent and Trademark Resource Centers (PTRCs): Local PTRCs offer training in patent search techniques and maintain local search resources, which can be invaluable for conducting thorough analyses[1].

  • Common Citation Document (CCD): The CCD application consolidates prior art cited by participating offices, providing a single point of access to citation data related to the patent family[1].

Case Studies and Examples

Infringement Litigation

The '192 patent could be involved in infringement litigation, similar to other patents in the same field. For example, if Perrigo were to develop a competing product that allegedly infringes on the '192 patent, this could lead to legal action. Perrigo might file an Abbreviated New Drug Application (ANDA) with certifications asserting that the claims of the '192 patent are invalid, unenforceable, or not infringed by their product[2].

Expert Insights

Industry experts often provide valuable insights into the patent landscape. For instance:

"The quality of patents is a critical issue in the patent system. Patents that are overly broad or lack clarity can diminish the incentives for innovation due to increased licensing and litigation costs."[3]

Statistics and Trends

  • Patent Litigation Increase: From 2000 to 2011, the number of patent infringement lawsuits in federal courts fluctuated but saw a significant increase in 2011, partly due to the anticipation of changes in the AIA[4].

  • Patent Scope Metrics: Research indicates that narrower claims at publication are associated with a higher probability of grant and a shorter examination process. The examination process tends to narrow the scope of patent claims, particularly when the duration of examination is longer[3].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for determining the scope of protection.
  • Patent Scope: The breadth of protection is influenced by the specificity and number of claims.
  • Industry Context: The regulatory environment and industry trends significantly impact the patent's value and litigation potential.
  • Litigation: The involvement of NPEs and the use of tools like the CCD can affect patent litigation.
  • Search Tools: Utilizing resources like the USPTO Public Search Facility and PTRCs is essential for thorough analysis.

FAQs

Q: What is the significance of independent claims in a patent? A: Independent claims define the invention broadly and stand alone, while dependent claims build upon these to provide more specific details.

Q: How does the Leahy-Smith America Invents Act (AIA) impact patent litigation? A: The AIA introduced changes that limited the number of defendants in lawsuits and affected the types of patents involved in litigation, leading to an increase in the number of lawsuits.

Q: What is the role of Non-Practicing Entities (NPEs) in patent litigation? A: NPEs own patents but do not make products, focusing on licensing and asserting patents for profit, which can increase litigation costs and complexity.

Q: How can the Common Citation Document (CCD) aid in patent analysis? A: The CCD consolidates prior art cited by participating offices, providing a single point of access to citation data related to the patent family.

Q: What metrics can be used to measure patent scope? A: Metrics such as independent claim length and count can be used to measure patent scope, with narrower claims often associated with a higher probability of grant and a shorter examination process[3].

Sources

  1. USPTO: Search for patents - USPTO.
  2. IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT: IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT ...
  3. SSRN: Patent Claims and Patent Scope - Search eLibrary :: SSRN.
  4. GAO: Assessing Factors That Affect Patent Infringement Litigation ... - GAO.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,543,192

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Journey QBREXZA glycopyrronium tosylate CLOTH;TOPICAL 210361-001 Jun 28, 2018 RX Yes Yes 10,543,192 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,543,192

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014223172 ⤷  Subscribe
Australia 2016269524 ⤷  Subscribe
Canada 2902795 ⤷  Subscribe
China 105026369 ⤷  Subscribe
European Patent Office 2961734 ⤷  Subscribe
European Patent Office 3473615 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.